In breast cancer cells, CDK12 is frequently amplified together with its neighbouring HER2 gene and it was shown to drive tumour initiation and progression by activating signaling pathways that promote self‐renewal of cancer stem cells [153]. This evidence concerns the gene ERBB2 and breast carcinoma.